ICOS and Miyoshi myopathy: In addition, increased expression of the receptors inducible T-cell costimulator (ICOS) and glucocorticoid-induced TNFR-related protein (GITR), which are potential targets for therapeutic antibodies, was noted on NK cells from the BM microenvironment of MM patients.